FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Gao, H
   Korn, JM
   Ferretti, S
   Monahan, JE
   Wang, YZ
   Singh, M
   Zhang, C
   Schnell, C
   Yang, GZ
   Zhang, Y
   Balbin, OA
   Barbe, S
   Cai, HB
   Casey, F
   Chatterjee, S
   Chiang, DY
   Chuai, S
   Cogan, SM
   Collins, SD
   Dammassa, E
   Ebel, N
   Embry, M
   Green, J
   Kauffmann, A
   Kowa, C
   Leary, RJ
   Lehar, J
   Liang, Y
   Loo, A
   Lorenzana, E
   McDonald, ER
   McLaughlin, ME
   Merkin, J
   Meyer, R
   Naylor, TL
   Patawaran, M
   Reddy, A
   Roelli, C
   Ruddy, DA
   Salangsang, F
   Santacroce, F
   Singh, AP
   Tang, Y
   Tinetto, W
   Tobler, S
   Velazquez, R
   Venkatesan, K
   Von Arx, F
   Wang, HQ
   Wang, ZY
   Wiesmann, M
   Wyss, D
   Xu, F
   Bitter, H
   Atadja, P
   Lees, E
   Hofmann, F
   Li, E
   Keen, N
   Cozens, R
   Jensen, MR
   Pryer, NK
   Williams, JA
   Sellers, WR
AF Gao, Hui
   Korn, Joshua M.
   Ferretti, Stephane
   Monahan, John E.
   Wang, Youzhen
   Singh, Mallika
   Zhang, Chao
   Schnell, Christian
   Yang, Guizhi
   Zhang, Yun
   Balbin, O. Alejandro
   Barbe, Stephanie
   Cai, Hongbo
   Casey, Fergal
   Chatterjee, Susmita
   Chiang, Derek Y.
   Chuai, Shannon
   Cogan, Shawn M.
   Collins, Scott D.
   Dammassa, Ernesta
   Ebel, Nicolas
   Embry, Millicent
   Green, John
   Kauffmann, Audrey
   Kowa, Colleen
   Leary, Rebecca J.
   Lehar, Joseph
   Liang, Ying
   Loo, Alice
   Lorenzana, Edward
   McDonald, E. Robert, III
   McLaughlin, Margaret E.
   Merkin, Jason
   Meyer, Ronald
   Naylor, Tara L.
   Patawaran, Montesa
   Reddy, Anupama
   Roeelli, Claudia
   Ruddy, David A.
   Salangsang, Fernando
   Santacroce, Francesca
   Singh, Angad P.
   Tang, Yan
   Tinetto, Walter
   Tobler, Sonja
   Velazquez, Roberto
   Venkatesan, Kavitha
   Von Arx, Fabian
   Wang, Hui Qin
   Wang, Zongyao
   Wiesmann, Marion
   Wyss, Daniel
   Xu, Fiona
   Bitter, Hans
   Atadja, Peter
   Lees, Emma
   Hofmann, Francesco
   Li, En
   Keen, Nicholas
   Cozens, Robert
   Jensen, Michael Rugaard
   Pryer, Nancy K.
   Williams, Juliet A.
   Sellers, William R.
TI High-throughput screening using patient-derived tumor xenografts to
   predict clinical trial drug response
SO NATURE MEDICINE
AB Profiling candidate therapeutics with limited cancer models during preclinical development hinders predictions of clinical efficacy and identifying factors that underlie heterogeneous patient responses for patient-selection strategies. We established similar to 1,000 patient-derived tumor xenograft models (PDXs) with a diverse set of driver mutations. With these PDXs, we performed in vivo compound screens using a 1 x 1 x 1 experimental design (PDX clinical trial or PCT) to assess the population responses to 62 treatments across six indications. We demonstrate both the reproducibility and the clinical translatability of this approach by identifying associations between a genotype and drug response, and established mechanisms of resistance. In addition, our results suggest that PCTs may represent a more accurate approach than cell line models for assessing the clinical potential of some therapeutic modalities. We therefore propose that this experimental paradigm could potentially improve preclinical evaluation of treatment modalities and enhance our ability to predict clinical trial responses.
RI wang, edwin/G-5372-2010; Chiang, Derek/L-6452-2019
OI Chiang, Derek/0000-0002-1131-6065; Monahan, John/0000-0002-3125-8704
SN 1078-8956
EI 1546-170X
PD NOV
PY 2015
VL 21
IS 11
BP 1318
EP 1325
DI 10.1038/nm.3954
UT WOS:000364621200016
PM 26479923
ER

EF